Abstract
We study in this work the temporal evolution of local and global contaminated population by coronavirus. We access those information analytically and numerically using a logistic model. It is shown, using diferent data from The Brazilian Ministry of Health (MS), The World Health Organization - WHO, and The Niteroi Health Foundation (FMS), the contaminated population ramping-up curves, the population inflection, the population saturation - plateau regime, and also the time related to these population evolution regimes. Based on the simulations, approaches are proposed at this more advanced phase of the pandemic, which might generate effectiveness at the actions of society in general, in a way that those actions could generate effective and efficient results, and this means a more organized war against this pandemic, a better way to induce the economy resumption, and also to create a more intense public awareness on the contamination hubs and surges that may emerge due to the reduction of social isolation.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NO CLINICAL TRIAL WAS PERFORMED, THE CORONAVIRUS EPIDEMIC DATA (ACTIVE PANDEMIC POPULATION) USED AT THIS WORK WAS THE ONES FROM THE OFFICIAL BRAZILIAN/CITY HEALTH AGENCIES (MS AND FMS), WE ALSO USED DATA FROM WHO. ALL REFERENCES ON THAT ARE DESCRIBED AT THE PAPER ABSTRACT/ARTICLE BODY/PAPER REFERENCES.
Funding Statement
Private funds
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
EXCEPTIONS U.S. regulations identify several research categories that are considered exempt from IRB oversight. These categories include: Research in conventional educational settings, such as those involving the study of instructional strategies or effectiveness of various techniques, curricula, or classroom management methods. In the case of studies involving the use of educational tests, there are specific provisions in the exemption to ensure that subjects cannot be identified or exposed to risks or liabilities. Research involving the analysis of existing data and other materials if they are already publicly available, or where the data can be collected such that individual subjects cannot be identified in any way. Studies intended to assess the performance or effectiveness of public benefit or service programs, or to evaluate food taste, quality, or consumer acceptance. Generally, human research ethics guidelines require that decisions about exemption are made by an IRB representative, not by the investigators themselves. https://en.wikipedia.org/wiki/Institutional_review_board#Exceptions
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
PUBLIC DATA
